United Therapeutics Corp. (UTHR)
United Therapeutics Market Cap : 24.50B for April 2, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| MannKind Corp. | 753.57M |
| Catalyst Pharmaceuticals, Inc. | 2.997B |
| Insmed, Inc. | 34.50B |
| Johnson & Johnson | 582.73B |
| Eli Lilly & Co. | 819.44B |
Market Cap Related Metrics
| PE Ratio | 20.24 |
| PS Ratio | 8.496 |
| PEG Ratio | 1.508 |
| Price to Book Value | 3.488 |
| Price to Free Cash Flow | 26.12 |
| Price | 564.81 |
| Earnings Yield | 4.94% |
| PEGY Ratio | 1.508 |
| Operating PE Ratio | 17.84 |
| Normalized PE Ratio | 20.52 |